Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients

Figure 1

The comparison of serum HMGB1 in 4 groups of 147 AS patients, which were divided according to the value of CRP and BASDAI. Data include serum HMGB1 levels of 147 AS patients which were divided into 4 groups, defined as group 1 (CRP > 10 mg/dL + BASDAI ≤ 4, ), group 2 (CRP > 10 mg/dL + BASDAI > 4, ), group 3 (CRP ≤ 10 mg/dL + BASDAI ≤ 4, ), and group 4 (CRP ≤ 10 mg/dL + BASDAI > 4, ). BASDAI: Bath AS Disease Activity Index; CRP: C-reactive protein. .